- Clinical Trials
- April 2024
- 180 Pages
Global
From €2878EUR$3,000USD£2,489GBP
- Report
- January 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,148GBP
- Report
- May 2024
- 174 Pages
Global
From €5229EUR$5,450USD£4,522GBP
- Report
- March 2024
- 148 Pages
Global
From €3741EUR$3,899USD£3,235GBP
- Report
- October 2023
- 145 Pages
Global
From €3022EUR$3,150USD£2,614GBP
- Report
- December 2023
- 117 Pages
Global
From €10550EUR$10,995USD£9,122GBP
- Report
- June 2022
- 148 Pages
Global
From €3790EUR$3,950USD£3,277GBP
- Report
- February 2020
- 253 Pages
Global
From €5997EUR$6,250USD£5,186GBP
- Report
- July 2022
- 120 Pages
Global
From €2399EUR$2,500USD£2,074GBP
- Report
- February 2021
Global
From €2840EUR$2,960USD£2,456GBP
- Report
- June 2022
- 67 Pages
Global
From €3353EUR$3,495USD£2,900GBP
- Report
- March 2021
- 120 Pages
Global
From €10550EUR$10,995USD£9,122GBP
- Report
- March 2021
- 30 Pages
Global
From €3833EUR$3,995USD£3,315GBP
- Report
- May 2022
- 153 Pages
Global
From €2399EUR$2,500USD£2,074GBP
- Report
- November 2023
- 55 Pages
China
From €1727EUR$1,800USD£1,493GBP
- Report
- February 2024
- 90 Pages
Global
From €3500EUR$3,908USD£3,132GBP
- Report
- February 2024
- 89 Pages
Global
From €3500EUR$3,908USD£3,132GBP
- Report
- November 2023
- 211 Pages
China
From €3838EUR$4,000USD£3,319GBP
The Major Depressive Disorder Drug market is a subset of the Mental Disorders Drugs market. It is composed of pharmaceuticals used to treat major depressive disorder, a mental health disorder characterized by persistent feelings of sadness, loss of interest, and fatigue. These drugs are typically prescribed by psychiatrists and other mental health professionals. Commonly prescribed drugs include selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), and monoamine oxidase inhibitors (MAOIs).
The Major Depressive Disorder Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, Eli Lilly, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, and Novartis. Show Less Read more